The role of microbiome in central nervous system disorders

Brain, Behavior, and Immunity

Volumn 38, Issue , 2014, Pages 1-12

  Wang, Yan ^a   Kasper, Lloyd H ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Central nervous system; Gut brain axis; Microbiome; Neuro immune disorders; Neuro psychiatric disorders

Indexed keywords

ANXIETY DISORDER; AUTISM; BRAIN MATURATION; CENTRAL NERVOUS SYSTEM DISEASE; CHRONIC FATIGUE SYNDROME; COMMENSALISM; DEPRESSION; EARLY LIFE STRESS; FECES MICROFLORA; GUILLAIN BARRE SYNDROME; HEPATIC ENCEPHALOPATHY; HOST SUSCEPTIBILITY; HUMAN; IMMUNE RESPONSE; IMMUNITY; MICROBIOME; MOLECULAR MIMICRY; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NEUROLOGIC DISEASE; NOCICEPTIVE PAIN; NONHUMAN; PRIORITY JOURNAL; REVIEW; SENSORY NERVE CELL; TH2 CELL; TRYPTOPHAN METABOLISM; CHRONIC INFLAMMATION; COEVOLUTION; COMORBIDITY; DIET; DISEASE PREDISPOSITION; DYSBIOSIS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; HYGIENE HYPOTHESIS; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; INTESTINE INNERVATION; INTESTINE MUCOSA PERMEABILITY; MENINGITIS; MENTAL STRESS; MICROBIAL COLONIZATION; VISCERAL PAIN; ANIMAL; BRAIN; GASTROINTESTINAL TRACT; MICROBIOLOGY; MICROFLORA;

ANTIBIOTIC AGENT; AQUAPORIN 4; BACTERIAL POLYSACCHARIDE; BACTERIUM LIPOPOLYSACCHARIDE; BRAIN DERIVED NEUROTROPHIC FACTOR; PROBIOTIC AGENT; SHORT CHAIN FATTY ACID;

ANIMALS; BRAIN; CENTRAL NERVOUS SYSTEM DISEASES; GASTROINTESTINAL TRACT; HUMANS; MICROBIOTA;

EID: 84898542916     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2013.12.015     Document Type: Review

References (159)

1. Abt M.C., Osborne L.C., Monticelli L.A., Doering T.A., Alenghat T., Sonnenberg G.F., Paley M.A., Antenus M., Williams K.L., Erikson J., Wherry E.J., Artis D. Commensal bacteria calibrate the activation threshold of innate antiviral immunity. Immunity 2012, 37:158-170.
2. Adams J.B., Johansen L.J., Powell L.D., Quig D., Rubin R.A. Gastrointestinal flora and gastrointestinal status in children with autism-comparisons to typical children and correlation with autism severity. BMC Gastroenterol. 2011, 11:22.
3. Ait-Belgnaoui A., Durand H., Cartier C., Chaumaz G., Eutamene H., Ferrier L., Houdeau E., Fioramonti J., Bueno L., Theodorou V. Prevention of gut leakiness by a probiotic treatment leads to attenuated HPA response to an acute psychological stress in rats. Psychoneuroendocrinology 2012, 37:1885-1895.
4. Ait-Belgnaoui A., Han W., Lamine F., Eutamene H., Fioramonti J., Bueno L., Theodorou V. Lactobacillus farciminis treatment suppresses stress induced visceral hypersensitivity: a possible action through interaction with epithelial cell cytoskeleton contraction. Gut 2006, 55:1090-1094.
5. Al-Asmakh M., Anuar F., Zadjali F., Rafter J., Pettersson S. Gut microbial communities modulating brain development and function. Gut Microbes 2012, 3:366-373.
6. Arseneault-Breard J., Rondeau I., Gilbert K., Girard S.A., Tompkins T.A., Godbout R., Rousseau G. Combination of Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 reduces post-myocardial infarction depression symptoms and restores intestinal permeability in a rat model. Brit. J. Nutr. 2012, 107:1793-1799.
7. Arumugam M., Raes J., Pelletier E., Le Paslier D., Yamada T., Mende D.R., Fernandes G.R., Tap J., Bruls T., Batto J.M., Bertalan M., Borruel N., Casellas F., Fernandez L., Gautier L., Hansen T., Hattori M., Hayashi T., Kleerebezem M., Kurokawa K., Leclerc M., Levenez F., Manichanh C., Nielsen H.B., Nielsen T., Pons N., Poulain J., Qin J., Sicheritz-Ponten T., Tims S., Torrents D., Ugarte E., Zoetendal E.G., Wang J., Guarner F., Pedersen O., de Vos W.M., Brunak S., Dore J., Antolin M., Artiguenave F., Blottiere H.M., Almeida M., Brechot C., Cara C., Chervaux C., Cultrone A., Delorme C., Denariaz G., Dervyn R., Foerstner K.U., Friss C., van de Guchte M., Guedon E., Haimet F., Huber W., van Hylckama-Vlieg J., Jamet A., Juste C., Kaci G., Knol J., Lakhdari O., Layec S., Le Roux K., Maguin E., Merieux A., Melo Minardi R., M'Rini C., Muller J., Oozeer R., Parkhill J., Renault P., Rescigno M., Sanchez N., Sunagawa S., Torrejon A., Turner K., Vandemeulebrouck G., Varela E., Winogradsky Y., Zeller G., Weissenbach J., Ehrlich S.D., Bork P. Enterotypes of the human gut microbiome. Nature 2011, 473:174-180.
8. Bailey M.T., Dowd S.E., Galley J.D., Hufnagle A.R., Allen R.G., Lyte M. Exposure to a social stressor alters the structure of the intestinal microbiota: implications for stressor-induced immunomodulation. Brain Behav. Immun. 2011, 25:397-407.
9. Bajaj J.S., Gillevet P.M., Patel N.R., Ahluwalia V., Ridlon J.M., Kettenmann B., Schubert C.M., Sikaroodi M., Heuman D.M., Crossey M.M., Bell D.E., Hylemon P.B., Fatouros P.P., Taylor-Robinson S.D. A longitudinal systems biology analysis of lactulose withdrawal in hepatic encephalopathy. Metab. Brain Dis. 2012, 27:205-215.
10. Bajaj J.S., Hylemon P.B., Ridlon J.M., Heuman D.M., Daita K., White M.B., Monteith P., Noble N.A., Sikaroodi M., Gillevet P.M. Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation. Am. J. physiol. Gastrointest. Liver Physiol. 2012, 303:G675-G685.
11. Bajaj J.S., Ridlon J.M., Hylemon P.B., Thacker L.R., Heuman D.M., Smith S., Sikaroodi M., Gillevet P.M. Linkage of gut microbiome with cognition in hepatic encephalopathy. Am. J. physiol. Gastrointest. Liver Physiol. 2012, 302:G168-G175.
12. Banati M., Csecsei P., Koszegi E., Nielsen H.H., Suto G., Bors L., Trauninger A., Csepany T., Rozsa C., Jakab G., Molnar T., Berthele A., Kalluri S.R., Berki T., Illes Z. Antibody response against gastrointestinal antigens in demyelinating diseases of the central nervous system. Eur. J. Neurol. 2013.
13. Barajon I., Serrao G., Arnaboldi F., Opizzi E., Ripamonti G., Balsari A., Rumio C. Toll-like receptors 3, 4, and 7 are expressed in the enteric nervous system and dorsal root ganglia. J. Histochem. Cytochem. 2009, 57:1013-1023.
14. Barrett E., Ross R.P., O'Toole P.W., Fitzgerald G.F., Stanton C. Gamma-aminobutyric acid production by culturable bacteria from the human intestine. J. Appl. Microbiol. 2012, 113:411-417.
15. Baxter A.G. The origin and application of experimental autoimmune encephalomyelitis. Nat. Rev. Immunol. 2007, 7:904-912.
16. Belkaid Y., Naik S. Compartmentalized and systemic control of tissue immunity by commensals. Nat. Immunol. 2013, 14:646-653.
17. Bercik P., Denou E., Collins J., Jackson W., Lu J., Jury J., Deng Y., Blennerhassett P., Macri J., McCoy K.D., Verdu E.F., Collins S.M. The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology 2011, 141:599-609. 609 e591-e593.
18. Bercik P., Park A.J., Sinclair D., Khoshdel A., Lu J., Huang X., Deng Y., Blennerhassett P.A., Fahnestock M., Moine D., Berger B., Huizinga J.D., Kunze W., McLean P.G., Bergonzelli G.E., Collins S.M., Verdu E.F. The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication. Neurogastroenterol. Motil. 2011, 23:1132-1139.
19. Bercik P., Verdu E.F., Foster J.A., Macri J., Potter M., Huang X., Malinowski P., Jackson W., Blennerhassett P., Neufeld K.A., Lu J., Khan W.I., Corthesy-Theulaz I., Cherbut C., Bergonzelli G.E., Collins S.M. Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice. Gastroenterology 2010, 139(2102-2112):e2101.
20. Berer K., Krishnamoorthy G. Commensal gut flora and brain autoimmunity: a love or hate affair?. Acta Neuropathol. 2012, 123:639-651.
21. Berer K., Mues M., Koutrolos M., Rasbi Z.A., Boziki M., Johner C., Wekerle H., Krishnamoorthy G. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature 2011, 479:538-541.
22. Bolte E.R. Autism and Clostridium tetani. Med. Hypotheses 1998, 51:133-144.
23. Bonaz B.L., Bernstein C.N. Brain-gut interactions in inflammatory bowel disease. Gastroenterology 2013, 144:36-49.
24. Brahic M. Multiple sclerosis and viruses. Ann. Neurol. 2010, 68:6-8.
25. Branton W.G., Ellestad K.K., Maingat F., Wheatley B.M., Rud E., Warren R.L., Holt R.A., Surette M.G., Power C. Brain microbial populations in HIV/AIDS: alpha-proteobacteria predominate independent of host immune status. PLoS One 2013, 8:e54673.
26. Bravo J.A., Forsythe P., Chew M.V., Escaravage E., Savignac H.M., Dinan T.G., Bienenstock J., Cryan J.F. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:16050-16055.
27. Brown E.M., Sadarangani M., Finlay B.B. The role of the immune system in governing host-microbe interactions in the intestine. Nat. Immunol. 2013, 14:660-667.
28. Brun P., Giron M.C., Qesari M., Porzionato A., Caputi V., Zoppellaro C., Banzato S., Grillo A.R., Spagnol L., De Caro R., Pizzuti D., Barbieri V., Rosato A., Sturniolo G.C., Martines D., Zaninotto G., Palu G., Castagliuolo I. Toll-like receptor 2 regulates intestinal inflammation by controlling integrity of the enteric nervous system. Gastroenterology 2013.
29. Cecon F., Ferreira L.E., Rosa R.T., Gursky L.C., de Paula e Carvalho A., Samaranayake L.P., Rosa E.A. Time-related increase of staphylococci, Enterobacteriaceae and yeasts in the oral cavities of comatose patients. J. Microbiol. Immunol. Infect. 2010, 43:457-463.
30. Chiu I.M., Heesters B.A., Ghasemlou N., Von Hehn C.A., Zhao F., Tran J., Wainger B., Strominger A., Muralidharan S., Horswill A.R., Wardenburg J.B., Hwang S.W., Carroll M.C., Woolf C.J. Bacteria activate sensory neurons that modulate pain and inflammation. Nature 2013.
31. Clarke G., Grenham S., Scully P., Fitzgerald P., Moloney R.D., Shanahan F., Dinan T.G., Cryan J.F. The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol. Psychiatry 2013, 18:666-673.
32. Clarke M.B., Hughes D.T., Zhu C., Boedeker E.C., Sperandio V. The QseC sensor kinase: a bacterial adrenergic receptor. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:10420-10425.
33. Collins S.M., Denou E., Verdu E.F., Bercik P. The putative role of the intestinal microbiota in the irritable bowel syndrome. Digest. Liver Dis. 2009, 41:850-853.
34. Corthesy B. Multi-faceted functions of secretory IgA at mucosal surfaces. Front. Immunol. 2013, 4:185.
35. Cotillard A., Kennedy S.P., Kong L.C., Prifti E., Pons N., Le Chatelier E., Almeida M., Quinquis B., Levenez F., Galleron N., Gougis S., Rizkalla S., Batto J.M., Renault P., Dore J., Zucker J.D., Clement K., Ehrlich S.D., Blottiere H., Leclerc M., Juste C., de Wouters T., Lepage P., Fouqueray C., Basdevant A., Henegar C., Godard C., Fondacci M., Rohia A., Hajduch F., Weissenbach J., Pelletier E., Le Paslier D., Gauchi J.P., Gibrat J.F., Loux V., Carre W., Maguin E., van de Guchte M., Jamet A., Boumezbeur F., Layec S. Dietary intervention impact on gut microbial gene richness. Nature 2013, 500:585-588.
36. Cryan J.F., Dinan T.G. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat. Rev. Neurosci. 2012, 13:701-712.
37. Cummings D.E., Overduin J. Gastrointestinal regulation of food intake. J. Clin. Investig. 2007, 117:13-23.
38. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 2008, 9:46-56.
39. Davari S., Talaei S.A., Alaei H., Salami M. Probiotics treatment improves diabetes-induced impairment of synaptic activity and cognitive function: behavioral and electrophysiological proofs for microbiome-gut-brain axis. Neuroscience 2013, 240:287-296.
40. de Lartigue G., de La Serre C.B., Raybould H.E. Vagal afferent neurons in high fat diet-induced obesity; intestinal microflora, gut inflammation and cholecystokinin. Physiol. Behav. 2011, 105:100-105.
41. de Theije C.G., Wopereis H., Ramadan M., van Eijndthoven T., Lambert J., Knol J., Garssen J., Kraneveld A.D., Oozeer R. Altered gut microbiota and activity in a murine model of autism spectrum disorders. Brain Behav. Immun. 2014, 37:197-206.
42. Desbonnet L., Garrett L., Clarke G., Bienenstock J., Dinan T.G. The probiotic Bifidobacteria infantis: an assessment of potential antidepressant properties in the rat. J. Psychiatr. Res. 2008, 43:164-174.
43. Desbonnet L., Garrett L., Clarke G., Kiely B., Cryan J.F., Dinan T.G. Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience 2010, 170:1179-1188.
44. Diamond B., Huerta P.T., Tracey K., Volpe B.T. It takes guts to grow a brain: increasing evidence of the important role of the intestinal microflora in neuro- and immune-modulatory functions during development and adulthood. Bioessays 2011, 33:588-591.
45. Diaz Heijtz R., Wang S., Anuar F., Qian Y., Bjorkholm B., Samuelsson A., Hibberd M.L., Forssberg H., Pettersson S. Normal gut microbiota modulates brain development and behavior. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:3047-3052.
46. Dinan T.G., Cryan J.F. Regulation of the stress response by the gut microbiota: implications for psychoneuroendocrinology. Psychoneuroendocrinology 2012, 37:1369-1378.
47. Douglas-Escobar M., Elliott E., Neu J. Effect of intestinal microbial ecology on the developing brain. JAMA Pediatr. 2013, 167:374-379.
48. Dubin P.J., Kolls J.K. Th17 cytokines and mucosal immunity. Immunol. Rev. 2008, 226:160-171.
49. Ezendam J., de Klerk A., Gremmer E.R., van Loveren H. Effects of Bifidobacterium animalis administered during lactation on allergic and autoimmune responses in rodents. Clin. Exp. Immunol. 2008, 154:424-431.
50. Ezendam J., van Loveren H. Lactobacillus casei Shirota administered during lactation increases the duration of autoimmunity in rats and enhances lung inflammation in mice. Brit. J. Nutr. 2008, 99:83-90.
51. Fava F., Danese S. Intestinal microbiota in inflammatory bowel disease: friend of foe?. World J. Gastroenterol. 2011, 17:557-566.
52. Finegold S.M., Dowd S.E., Gontcharova V., Liu C., Henley K.E., Wolcott R.D., Youn E., Summanen P.H., Granpeesheh D., Dixon D., Liu M., Molitoris D.R., Green J.A. Pyrosequencing study of fecal microflora of autistic and control children. Anaerobe 2010, 16:444-453.
53. Finegold S.M., Molitoris D., Song Y., Liu C., Vaisanen M.L., Bolte E., McTeague M., Sandler R., Wexler H., Marlowe E.M., Collins M.D., Lawson P.A., Summanen P., Baysallar M., Tomzynski T.J., Read E., Johnson E., Rolfe R., Nasir P., Shah H., Haake D.A., Manning P., Kaul A. Gastrointestinal microflora studies in late-onset autism. Clin. Infect. Dis. 2002, 35:S6-S16.
54. Forsythe P., Sudo N., Dinan T., Taylor V.H., Bienenstock J. Mood and gut feelings. Brain Behav. Immun. 2010, 24:9-16.
55. Frank D.N., St Amand A.L., Feldman R.A., Boedeker E.C., Harpaz N., Pace N.R. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:13780-13785.
56. Fukudo S., Kanazawa M. Gene, environment, and brain-gut interactions in irritable bowel syndrome. J. Gastroenterol. Hepatol. 2011, 26(Suppl. 3):110-115.
57. Gareau M.G., Jury J., MacQueen G., Sherman P.M., Perdue M.H. Probiotic treatment of rat pups normalises corticosterone release and ameliorates colonic dysfunction induced by maternal separation. Gut 2007, 56:1522-1528.
58. Gareau M.G., Wine E., Rodrigues D.M., Cho J.H., Whary M.T., Philpott D.J., Macqueen G., Sherman P.M. Bacterial infection causes stress-induced memory dysfunction in mice. Gut 2011, 60:307-317.
59. Garrett W.S., Lord G.M., Punit S., Lugo-Villarino G., Mazmanian S.K., Ito S., Glickman J.N., Glimcher L.H. Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell 2007, 131:33-45.
60. Gaykema R.P., Goehler L.E., Lyte M. Brain response to cecal infection with Campylobacter jejuni: analysis with Fos immunohistochemistry. Brain Behav. Immun. 2004, 18:238-245.
61. Gilbert K., Arseneault-Breard J., Flores Monaco F., Beaudoin A., Bah T.M., Tompkins T.A., Godbout R., Rousseau G. Attenuation of post-myocardial infarction depression in rats by n-3 fatty acids or probiotics starting after the onset of reperfusion. Brit. J. Nutr. 2013, 109:50-56.
62. Goehler L.E., Park S.M., Opitz N., Lyte M., Gaykema R.P. Campylobacter jejuni infection increases anxiety-like behavior in the holeboard: possible anatomical substrates for viscerosensory modulation of exploratory behavior. Brain Behav. Immun. 2008, 22:354-366.
63. Gondalia S.V., Palombo E.A., Knowles S.R., Cox S.B., Meyer D., Austin D.W. Molecular characterisation of gastrointestinal microbiota of children with autism (with and without gastrointestinal dysfunction) and their neurotypical siblings. Autism Res. 2012, 5:419-427.
64. Gonzalez-Rey E., Fernandez-Martin A., Chorny A., Martin J., Pozo D., Ganea D., Delgado M. Therapeutic effect of vasoactive intestinal peptide on experimental autoimmune encephalomyelitis: down-regulation of inflammatory and autoimmune responses. Am. J. Pathol. 2006, 168:1179-1188.
65. Gundersen B.B., Blendy J.A. Effects of the histone deacetylase inhibitor sodium butyrate in models of depression and anxiety. Neuropharmacology 2009, 57:67-74.
66. Hemarajata P., Versalovic J. Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation. Therapeut. Adv. Gastroenterol. 2013, 6:39-51.
67. Hildebrand F., Nguyen T.L., Brinkman B., Yunta R.G., Cauwe B., Vandenabeele P., Liston A., Raes J. Inflammation-associated enterotypes, host genotype, cage and inter-individual effects drive gut microbiota variation in common laboratory mice. Genome Biol. 2013, 14:R4.
68. Holmes E., Li J.V., Athanasiou T., Ashrafian H., Nicholson J.K. Understanding the role of gut microbiome-host metabolic signal disruption in health and disease. Trends Microbiol. 2011, 19:349-359.
69. Hooper L.V., Wong M.H., Thelin A., Hansson L., Falk P.G., Gordon J.I. Molecular analysis of commensal host-microbial relationships in the intestine. Science (New York, NY) 2001, 291:881-884.
70. Hsiao E.Y., McBride S.W., Hsien S., Sharon G., Hyde E.R., McCue T., Codelli J.A., Chow J., Reisman S.E., Petrosino J.F., Patterson P.H., Mazmanian S.K. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 2013, 155:1451-1463.
71. Ichinohe T., Pang I.K., Kumamoto Y., Peaper D.R., Ho J.H., Murray T.S., Iwasaki A. Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:5354-5359.
72. Jimenez E., Marin M.L., Martin R., Odriozola J.M., Olivares M., Xaus J., Fernandez L., Rodriguez J.M. Is meconium from healthy newborns actually sterile?. Res. Microbiol. 2008, 159:187-193.
73. Johnson A.C., Greenwood-Van Meerveld B., McRorie J. Effects of Bifidobacterium infantis 35624 on post-inflammatory visceral hypersensitivity in the rat. Dig. Dis. Sci. 2011, 56:3179-3186.
74. Kamiya T., Wang L., Forsythe P., Goettsche G., Mao Y., Wang Y., Tougas G., Bienenstock J. Inhibitory effects of Lactobacillus reuteri on visceral pain induced by colorectal distension in Sprague-Dawley rats. Gut 2006, 55:191-196.
75. Kang D.W., Park J.G., Ilhan Z.E., Wallstrom G., Labaer J., Adams J.B., Krajmalnik-Brown R. Reduced incidence of prevotella and other fermenters in intestinal microflora of autistic children. PLoS One 2013, 8:e68322.
76. Kassinen A., Krogius-Kurikka L., Makivuokko H., Rinttila T., Paulin L., Corander J., Malinen E., Apajalahti J., Palva A. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 2007, 133:24-33.
77. Khocht A., Yaskell T., Janal M., Turner B.F., Rams T.E., Haffajee A.D., Socransky S.S. Subgingival microbiota in adult Down syndrome periodontitis. J. Periodontal Res. 2012, 47:500-507.
78. Kleinewietfeld M., Manzel A., Titze J., Kvakan H., Yosef N., Linker R.A., Muller D.N., Hafler D.A. Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature 2013, 496:518-522.
79. Kobayashi T., Kato I., Nanno M., Shida K., Shibuya K., Matsuoka Y., Onoue M. Oral administration of probiotic bacteria, Lactobacillus casei and Bifidobacterium breve, does not exacerbate neurological symptoms in experimental autoimmune encephalomyelitis. Immunopharmacol. Immunotoxicol. 2010, 32:116-124.
80. Kobayashi T., Suzuki T., Kaji R., Serata M., Nagata T., Ando M., Iizuka R., Tsujibe S., Murakami J., Kiyoshima-Shibata J., Kato I., Nanno M., Shida K. Probiotic upregulation of peripheral IL-17 responses does not exacerbate neurological symptoms in experimental autoimmune encephalomyelitis mouse models. Immunopharmacol. Immunotoxicol. 2012, 34:423-433.
81. Konturek P.C., Brzozowski T., Konturek S.J. Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options. J. Physiol. Pharmacol. 2011, 62:591-599.
82. Koren O., Knights D., Gonzalez A., Waldron L., Segata N., Knight R., Huttenhower C., Ley R.E. A guide to enterotypes across the human body: meta-analysis of microbial community structures in human microbiome datasets. PLoS Comput. Biol. 2013, 9:e1002863.
83. Kunze W.A., Mao Y.K., Wang B., Huizinga J.D., Ma X., Forsythe P., Bienenstock J. Lactobacillus reuteri enhances excitability of colonic AH neurons by inhibiting calcium-dependent potassium channel opening. J. Cell Mol. Med. 2009, 13:2261-2270.
84. Kuss S.K., Best G.T., Etheredge C.A., Pruijssers A.J., Frierson J.M., Hooper L.V., Dermody T.S., Pfeiffer J.K. Intestinal microbiota promote enteric virus replication and systemic pathogenesis. Science (New York, NY) 2011, 334:249-252.
85. Kusu T., Kayama H., Kinoshita M., Jeon S.G., Ueda Y., Goto Y., Okumura R., Saiga H., Kurakawa T., Ikeda K., Maeda Y., Nishimura J., Arima Y., Atarashi K., Honda K., Murakami M., Kunisawa J., Kiyono H., Okumura M., Yamamoto M., Takeda K. Ecto-nucleoside triphosphate diphosphohydrolase 7 controls Th17 cell responses through regulation of luminal ATP in the small intestine. J. Immunol. (Baltimore, MD: 1950) 2013, 190:774-783.
86. Kwon H.K., Kim G.C., Kim Y., Hwang W., Jash A., Sahoo A., Kim J.E., Nam J.H., Im S.H. Amelioration of experimental autoimmune encephalomyelitis by probiotic mixture is mediated by a shift in T helper cell immune response. Clin. Immunol. (Orlando, FL) 2013, 146:217-227.
87. Lavasani S., Dzhambazov B., Nouri M., Fak F., Buske S., Molin G., Thorlacius H., Alenfall J., Jeppsson B., Westrom B. A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells. PLoS One 2010, 5:e9009.
88. Le Chatelier E., Nielsen T., Qin J., Prifti E., Hildebrand F., Falony G., Almeida M., Arumugam M., Batto J.M., Kennedy S., Leonard P., Li J., Burgdorf K., Grarup N., Jorgensen T., Brandslund I., Nielsen H.B., Juncker A.S., Bertalan M., Levenez F., Pons N., Rasmussen S., Sunagawa S., Tap J., Tims S., Zoetendal E.G., Brunak S., Clement K., Dore J., Kleerebezem M., Kristiansen K., Renault P., Sicheritz-Ponten T., de Vos W.M., Zucker J.D., Raes J., Hansen T., Bork P., Wang J., Ehrlich S.D., Pedersen O., Guedon E., Delorme C., Layec S., Khaci G., van de Guchte M., Vandemeulebrouck G., Jamet A., Dervyn R., Sanchez N., Maguin E., Haimet F., Winogradski Y., Cultrone A., Leclerc M., Juste C., Blottiere H., Pelletier E., LePaslier D., Artiguenave F., Bruls T., Weissenbach J., Turner K., Parkhill J., Antolin M., Manichanh C., Casellas F., Boruel N., Varela E., Torrejon A., Guarner F., Denariaz G., Derrien M., van Hylckama Vlieg J.E., Veiga P., Oozeer R., Knol J., Rescigno M., Brechot C., M'Rini C., Merieux A., Yamada T. Richness of human gut microbiome correlates with metabolic markers. Nature 2013, 500:541-546.
89. Lee Y.K., Menezes J.S., Umesaki Y., Mazmanian S.K. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. U.S.A. 2011, 108(Suppl 1):4615-4622.
90. Lennon V.A., Kryzer T.J., Pittock S.J., Verkman A.S., Hinson S.R. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J. Exp. Med. 2005, 202:473-477.
91. Li W., Dowd S.E., Scurlock B., Acosta-Martinez V., Lyte M. Memory and learning behavior in mice is temporally associated with diet-induced alterations in gut bacteria. Physiol. Behav. 2009, 96:557-567.
92. Lyte M. Probiotics function mechanistically as delivery vehicles for neuroactive compounds: microbial endocrinology in the design and use of probiotics. Bioessays 2011, 33:574-581.
93. Lyte M., Li W., Opitz N., Gaykema R.P., Goehler L.E. Induction of anxiety-like behavior in mice during the initial stages of infection with the agent of murine colonic hyperplasia Citrobacter rodentium. Physiol. Behav. 2006, 89:350-357.
94. Maassen C.B., Claassen E. Strain-dependent effects of probiotic lactobacilli on EAE autoimmunity. Vaccine 2008, 26:2056-2057.
95. MacFabe D.F., Cain N.E., Boon F., Ossenkopp K.P., Cain D.P. Effects of the enteric bacterial metabolic product propionic acid on object-directed behavior, social behavior, cognition, and neuroinflammation in adolescent rats: relevance to autism spectrum disorder. Behav. Brain Res. 2011, 217:47-54.
96. Macpherson A., Khoo U.Y., Forgacs I., Philpott-Howard J., Bjarnason I. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Gut 1996, 38:365-375.
97. Maes M., Twisk F.N., Kubera M., Ringel K., Leunis J.C., Geffard M. Increased IgA responses to the LPS of commensal bacteria is associated with inflammation and activation of cell-mediated immunity in chronic fatigue syndrome. J. Affect. Disord. 2012, 136:909-917.
98. Malinen E., Rinttila T., Kajander K., Matto J., Kassinen A., Krogius L., Saarela M., Korpela R., Palva A. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am. J. Gastroenterol. 2005, 100:373-382.
99. Mao Y.K., Kasper D.L., Wang B., Forsythe P., Bienenstock J., Kunze W.A. Bacteroides fragilis polysaccharide A is necessary and sufficient for acute activation of intestinal sensory neurons. Nat. Commun. 2013, 4:1465.
100. Mazmanian S.K., Liu C.H., Tzianabos A.O., Kasper D.L. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 2005, 122:107-118.
101. Mazmanian S.K., Round J.L., Kasper D.L. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 2008, 453:620-625.
102. McKernan D.P., Fitzgerald P., Dinan T.G., Cryan J.F. The probiotic Bifidobacterium infantis 35624 displays visceral antinociceptive effects in the rat. Neurogastroenterol. Motil. 2010, 22(1029-1035):e1268.
103. Messaoudi M., Lalonde R., Violle N., Javelot H., Desor D., Nejdi A., Bisson J.F., Rougeot C., Pichelin M., Cazaubiel M., Cazaubiel J.M. Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Brit. J. Nutr. 2011, 105:755-764.
104. Ming X., Stein T.P., Barnes V., Rhodes N., Guo L. Metabolic perturbance in autism spectrum disorders: a metabolomics study. J. Proteome Res. 2012, 11:5856-5862.
105. Morinushi T., Lopatin D.E., Van Poperin N. The relationship between gingivitis and the serum antibodies to the microbiota associated with periodontal disease in children with Down's syndrome. J. Periodontol. 1997, 68:626-631.
106. Mulle J.G., Sharp W.G., Cubells J.F. The gut microbiome: a new frontier in autism research. Curr. Psychiatry Rep. 2013, 15:337.
107. Nachamkin I., Allos B.M., Ho T. Campylobacter species and Guillain-Barre syndrome. Clin. Microbiol. Rev. 1998, 11:555-567.
108. Neufeld K.M., Kang N., Bienenstock J., Foster J.A. Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterol. Motil. 2011, 23(255-264):e119.
109. Nichols F.C., Housley W.J., O'Conor C.A., Manning T., Wu S., Clark R.B. Unique lipids from a common human bacterium represent a new class of Toll-like receptor 2 ligands capable of enhancing autoimmunity. Am. J. Pathol. 2009, 175:2430-2438.
110. O'Hara A.M., Shanahan F. The gut flora as a forgotten organ. EMBO Rep. 2006, 7:688-693.
111. O'Mahony S.M., Marchesi J.R., Scully P., Codling C., Ceolho A.M., Quigley E.M., Cryan J.F., Dinan T.G. Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses. Biol. Psychiatry 2009, 65:263-267.
112. O'Malley D., Quigley E.M., Dinan T.G., Cryan J.F. Do interactions between stress and immune responses lead to symptom exacerbations in irritable bowel syndrome?. Brain Behav. Immun. 2011, 25:1333-1341.
113. Ochoa-Reparaz J., Mielcarz D.W., Begum-Haque S., Kasper L.H. Gut, bugs, and brain: role of commensal bacteria in the control of central nervous system disease. Ann. Neurol. 2011, 69:240-247.
114. Ochoa-Reparaz J., Mielcarz D.W., Ditrio L.E., Burroughs A.R., Begum-Haque S., Dasgupta S., Kasper D.L., Kasper L.H. Central nervous system demyelinating disease protection by the human commensal Bacteroides fragilis depends on polysaccharide A expression. J. Immunol. (Baltimore, MD: 1950) 2010, 185:4101-4108.
115. Ochoa-Reparaz J., Mielcarz D.W., Ditrio L.E., Burroughs A.R., Foureau D.M., Haque-Begum S., Kasper L.H. Role of gut commensal microflora in the development of experimental autoimmune encephalomyelitis. J. Immunol. (Baltimore, MD: 1950) 2009, 183:6041-6050.
116. Ochoa-Reparaz J., Mielcarz D.W., Haque-Begum S., Kasper L.H. Induction of a regulatory B cell population in experimental allergic encephalomyelitis by alteration of the gut commensal microflora. Gut Microbes 2010, 1:103-108.
117. Ochoa-Reparaz J., Mielcarz D.W., Wang Y., Begum-Haque S., Dasgupta S., Kasper D.L., Kasper L.H. A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating disease. Mucosal Immunol. 2010, 3:487-495.
118. Ochoa-Reparaz J., Riccardi C., Rynda A., Jun S., Callis G., Pascual D.W. Regulatory T cell vaccination without autoantigen protects against experimental autoimmune encephalomyelitis. J. Immunol. (Baltimore, MD: 1950) 2007, 178:1791-1799.
119. Ochoa-Reparaz J., Rynda A., Ascon M.A., Yang X., Kochetkova I., Riccardi C., Callis G., Trunkle T., Pascual D.W. IL-13 production by regulatory T cells protects against experimental autoimmune encephalomyelitis independently of autoantigen. J. Immunol. (Baltimore, MD: 1950) 2008, 181:954-968.
120. Ohland C.L., Kish L., Bell H., Thiesen A., Hotte N., Pankiv E., Madsen K.L. Effects of Lactobacillus helveticus on murine behavior are dependent on diet and genotype and correlate with alterations in the gut microbiome. Psychoneuroendocrinology 2013.
121. Olszak T., An D., Zeissig S., Vera M.P., Richter J., Franke A., Glickman J.N., Siebert R., Baron R.M., Kasper D.L., Blumberg R.S. Microbial exposure during early life has persistent effects on natural killer T cell function. Science (New York, NY) 2012, 336:489-493.
122. Palmer C., Bik E.M., DiGiulio D.B., Relman D.A., Brown P.O. Development of the human infant intestinal microbiota. PLoS Biol. 2007, 5:e177.
123. Parracho H.M., Bingham M.O., Gibson G.R., McCartney A.L. Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. J. Med. Microbiol. 2005, 54:987-991.
124. Patarca-Montero R., Antoni M., Fletcher M.A., Klimas N.G. Cytokine and other immunologic markers in chronic fatigue syndrome and their relation to neuropsychological factors. Appl. Neuropsychol. 2001, 8:51-64.
125. Piccio L., Stark J.L., Cross A.H. Chronic calorie restriction attenuates experimental autoimmune encephalomyelitis. J. Leukoc. Biol. 2008, 84:940-948.
126. Rakoff-Nahoum S., Paglino J., Eslami-Varzaneh F., Edberg S., Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004, 118:229-241.
127. Reber S.O. Stress and animal models of inflammatory bowel disease-an update on the role of the hypothalamo-pituitary-adrenal axis. Psychoneuroendocrinology 2012, 37:1-19.
128. Rezende R.M., Oliveira R.P., Medeiros S.R., Gomes-Santos A.C., Alves A.C., Loli F.G., Guimaraes M.A., Amaral S.S., da Cunha A.P., Weiner H.L., Azevedo V., Miyoshi A., Faria A.M. Hsp65-producing Lactococcus lactis prevents experimental autoimmune encephalomyelitis in mice by inducing CD4+LAP+ regulatory T cells. J. Autoimmun. 2013, 40:45-57.
129. Rhee S.H., Pothoulakis C., Mayer E.A. Principles and clinical implications of the brain-gut-enteric microbiota axis. Nat. Rev. 2009, 6:306-314.
130. Romijn J.A., Corssmit E.P., Havekes L.M., Pijl H. Gut-brain axis. Curr. Opin. Clin. Nutr. Metab. Care 2008, 11:518-521.
131. Rook G.A., Lowry C.A., Raison C.L. Lymphocytes in neuroprotection, cognition and emotion: is intolerance really the answer?. Brain Behav. Immun. 2011, 25:591-601.
132. Round J.L., Mazmanian S.K. The gut microbiota shapes intestinal immune responses during health and disease. Nat. Rev. Immunol. 2009, 9:313-323.
133. Round J.L., Mazmanian S.K. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:12204-12209.
134. Rousseaux C., Thuru X., Gelot A., Barnich N., Neut C., Dubuquoy L., Dubuquoy C., Merour E., Geboes K., Chamaillard M., Ouwehand A., Leyer G., Carcano D., Colombel J.F., Ardid D., Desreumaux P. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nat. Med. 2007, 13:35-37.
135. Ruddick J.P., Evans A.K., Nutt D.J., Lightman S.L., Rook G.A., Lowry C.A. Tryptophan metabolism in the central nervous system: medical implications. Expert Rev. Mol. Med. 2006, 8:1-27.
136. Sandler R.H., Finegold S.M., Bolte E.R., Buchanan C.P., Maxwell A.P., Vaisanen M.L., Nelson M.N., Wexler H.M. Short-term benefit from oral vancomycin treatment of regressive-onset autism. J. Child Neurol. 2000, 15:429-435.
137. Santos J., Yang P.C., Soderholm J.D., Benjamin M., Perdue M.H. Role of mast cells in chronic stress induced colonic epithelial barrier dysfunction in the rat. Gut 2001, 48:630-636.
138. Sawa S., Lochner M., Satoh-Takayama N., Dulauroy S., Berard M., Kleinschek M., Cua D., Di Santo J.P., Eberl G. RORgammat+ innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota. Nat. Immunol. 2011, 12:320-326.
139. Sekirov I., Russell S.L., Antunes L.C., Finlay B.B. Gut microbiota in health and disease. Physiol. Rev. 2010, 90:859-904.
140. Severance E.G., Gressitt K.L., Stallings C.R., Origoni A.E., Khushalani S., Leweke F.M., Dickerson F.B., Yolken R.H. Discordant patterns of bacterial translocation markers and implications for innate immune imbalances in schizophrenia. Schizophr. Res. 2013, 148:130-137.
141. Smith P.M., Howitt M.R., Panikov N., Michaud M., Gallini C.A., Bohlooly Y.M., Glickman J.N., Garrett W.S. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science (New York, NY) 2013, 341:569-573.
142. Sudo N. Role of microbiome in regulating the HPA axis and its relevance to allergy. Chem. Immunol. Allergy 2012, 98:163-175.
143. Sudo N., Chida Y., Aiba Y., Sonoda J., Oyama N., Yu X.N., Kubo C., Koga Y. Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J. Physiol. 2004, 558:263-275.
144. Takata K., Kinoshita M., Okuno T., Moriya M., Kohda T., Honorat J.A., Sugimoto T., Kumanogoh A., Kayama H., Takeda K., Sakoda S., Nakatsuji Y. The lactic acid bacterium Pediococcus acidilactici suppresses autoimmune encephalomyelitis by inducing IL-10-producing regulatory T cells. PLoS One 2011, 6:e27644.
145. Tam C.C., O'Brien S.J., Petersen I., Islam A., Hayward A., Rodrigues L.C. Guillain-Barre syndrome and preceding infection with campylobacter, influenza and Epstein-Barr virus in the general practice research database. PLoS One 2007, 2:e344.
146. Thomas R.H., Meeking M.M., Mepham J.R., Tichenoff L., Possmayer F., Liu S., MacFabe D.F. The enteric bacterial metabolite propionic acid alters brain and plasma phospholipid molecular species: further development of a rodent model of autism spectrum disorders. J. Neuroinflamm. 2012, 9:153.
147. Valles Y., Gosalbes M.J., de Vries L.E., Abellan J.J., Francino M.P. Metagenomics and development of the gut microbiota in infants. Clin. Microbiol. 2012, 18(Suppl. 4):21-26.
148. Varrin-Doyer M., Spencer C.M., Schulze-Topphoff U., Nelson P.A., Stroud R.M., Cree B.A.C., Zamvil S.S. Aquaporin 4-specific t cells in neuromyelitis optica exhibit a Th17 bias and recognize clostridium ABC transporter. Ann. Neurol. 2012, 72:53-64.
149. Velickovic K., Markelic M., Golic I., Otasevic V., Stancic A., Jankovic A., Vucetic M., Buzadzic B., Korac B., Korac A. Long-term dietary L-arginine supplementation increases endothelial nitric oxide synthase and vasoactive intestinal peptide immunoexpression in rat small intestine. Eur. J. Nutr. 2013.
150. Verdu E.F. Probiotics effects on gastrointestinal function: beyond the gut?. Neurogastroenterol. Motil. 2009, 21:477-480.
151. Verdu E.F., Bercik P., Verma-Gandhu M., Huang X.X., Blennerhassett P., Jackson W., Mao Y., Wang L., Rochat F., Collins S.M. Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice. Gut 2006, 55:182-190.
152. Wang L., Christophersen C.T., Sorich M.J., Gerber J.P., Angley M.T., Conlon M.A. Elevated fecal short chain fatty acid and ammonia concentrations in children with autism spectrum disorder. Dig. Dis. Sci. 2012, 57:2096-2102.
153. Wang L., Christophersen C.T., Sorich M.J., Gerber J.P., Angley M.T., Conlon M.A. Increased abundance of Sutterella spp. and Ruminococcus torques in feces of children with autism spectrum disorder. Mol. Autism 2013, 4:42.
154. Williams B.L., Hornig M., Buie T., Bauman M.L., Cho Paik M., Wick I., Bennett A., Jabado O., Hirschberg D.L., Lipkin W.I. Impaired carbohydrate digestion and transport and mucosal dysbiosis in the intestines of children with autism and gastrointestinal disturbances. PLoS One 2011, 6:e24585.
155. Williams B.L., Hornig M., Parekh T., Lipkin W.I. Application of novel PCR-based methods for detection, quantitation, and phylogenetic characterization of Sutterella species in intestinal biopsy samples from children with autism and gastrointestinal disturbances. mBio 2012, 3.
156. Yap I.K., Angley M., Veselkov K.A., Holmes E., Lindon J.C., Nicholson J.K. Urinary metabolic phenotyping differentiates children with autism from their unaffected siblings and age-matched controls. J. Proteome Res. 2010, 9:2996-3004.
157. Yokote H., Miyake S., Croxford J.L., Oki S., Mizusawa H., Yamamura T. NKT cell-dependent amelioration of a mouse model of multiple sclerosis by altering gut flora. Am. J. Pathol. 2008, 173:1714-1723.
158. Zareie M., Johnson-Henry K., Jury J., Yang P.C., Ngan B.Y., McKay D.M., Soderholm J.D., Perdue M.H., Sherman P.M. Probiotics prevent bacterial translocation and improve intestinal barrier function in rats following chronic psychological stress. Gut 2006, 55:1553-1560.
159. Zelmer A., Bowen M., Jokilammi A., Finne J., Luzio J.P., Taylor P.W. Differential expression of the polysialyl capsule during blood-to-brain transit of neuropathogenic Escherichia coli K1. Microbiology (Reading, England) 2008, 154:2522-2532.